Shield Therapeutics PLC banner

Shield Therapeutics PLC
LSE:STX

Watchlist Manager
Shield Therapeutics PLC Logo
Shield Therapeutics PLC
LSE:STX
Watchlist
Price: 5.2 GBX 7.22% Market Closed
Market Cap: £55.6m

DCF Value

The DCF Value for Shield Therapeutics PLC (STX) under the Base Case is 19.16 GBX. Compared with the current market price of 5.2 GBX, the stock appears Undervalued by 73% .

Key assumptions
STX DCF Value
Base Case
19.16 GBX
Undervaluation 73%
DCF Value
Price 5.2 GBX
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time